트랜스펙션 기술 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 트랜스펙션 방법별, 제품별, 용도별, 기술별, 지역별, 경쟁별 세분화(2020-2030년)

The Global Transfection Technologies Market, valued at USD 3.03 Billion in 2024, is projected to experience a CAGR of 9.61% to reach USD 5.25 Billion by 2030. Transfection technologies encompass methods for introducing exogenous nucleic acids, such as DNA or RNA, into eukaryotic cells, enabling genetic modification for various research, therapeutic, and bioproduction applications. The market's growth is primarily driven by substantial global investments in life sciences research, escalating demand for gene and cell therapies, advancements in vaccine development, and expanding functional genomics initiatives, all requiring efficient nucleic acid delivery.

Key Market Drivers

The Global Transfection Technologies Market is significantly influenced by two critical factors: the growing demand for cell and gene therapies and continuous technological advancements in transfection methods and delivery systems. The expanding pipeline of cell and gene therapies directly necessitates robust and efficient nucleic acid delivery tools, crucial for the research, development, and eventual commercialization of these advanced therapeutic products.

Key Market Challenges

A significant challenge impeding market expansion stems from the inherent cytotoxicity and variable efficiency associated with certain transfection methods. These issues directly compromise cell viability and assay reproducibility, leading to increased experimental failures, extended research and development timelines, and substantial wastage of costly reagents and labor. Compromised cell viability necessitates repeated experiments, driving up operational expenditures for biopharmaceutical companies engaged in drug discovery and therapeutic development. Similarly, inconsistent transfection efficiency results in unreliable data, requiring extensive validation and re-evaluation, thereby slowing the progression of promising candidates from preclinical stages to clinical trials.

Key Market Trends

The integration with advanced gene editing technologies represents a pivotal evolution in transfection, moving beyond mere genetic material introduction to enabling precise and targeted genomic modifications within cells. The effective delivery of advanced gene editing tools, such as CRISPR-Cas systems, by transfection methods is instrumental in accelerating research for novel therapeutic applications and functional genomics. This integration facilitates the correction of specific disease-causing mutations and precise modulation of gene expression. The expanded utility in these highly targeted applications amplifies the demand for sophisticated delivery systems that ensure high efficiency, cell viability, and minimal off-target effects.

Key Market Players

• Promega Corporation
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Roche Molecular Systems, Inc.
• QIAGEN NV
• Inovio Pharmaceuticals
• Mirus Bio LLC
• Takara Bio Inc.
• SignaGen Laboratories
• MaxCyte, Inc.

Report Scope:

In this report, the Global Transfection Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Transfection Technologies Market, By Transfection Method:

• Cotransfection
• Electroporation
• Cationic Lipid Transfection
• Lipofection
• Nucleofection
• In Vivo Transfection

Transfection Technologies Market, By Product:

• Reagent
• Instrument
• Others

Transfection Technologies Market, By Application:

• Virus Production
• Protein Production
• Gene Silencing
• Stem Cell Reprogramming and Differentiation
• Stable Cell Line Generation
• Therapeutic Delivery
• Bio-Medical Research
• Others

Transfection Technologies Market, By Technology:

• Physical Transfection
• Biochemical Based Transfection
• Viral-Vector Based Transfection

Transfection Technologies Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Transfection Technologies Market.

Available Customizations:

Global Transfection Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Transfection Technologies Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Transfection Method (Cotransfection, Electroporation, Cationic Lipid Transfection, Lipofection, Nucleofection, In Vivo Transfection)
  • 5.2.2. By Product (Reagent, Instrument, Others)
  • 5.2.3. By Application (Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming and Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Bio-Medical Research, Others)
  • 5.2.4. By Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Transfection Technologies Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Transfection Method
  • 6.2.2. By Product
  • 6.2.3. By Application
  • 6.2.4. By Technology
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Transfection Technologies Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Transfection Method
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Technology
  • 6.3.2. Canada Transfection Technologies Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Transfection Method
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Technology
  • 6.3.3. Mexico Transfection Technologies Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Transfection Method
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Technology

7. Europe Transfection Technologies Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Transfection Method
  • 7.2.2. By Product
  • 7.2.3. By Application
  • 7.2.4. By Technology
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Transfection Technologies Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Transfection Method
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Technology
  • 7.3.2. France Transfection Technologies Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Transfection Method
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Technology
  • 7.3.3. United Kingdom Transfection Technologies Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Transfection Method
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Technology
  • 7.3.4. Italy Transfection Technologies Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Transfection Method
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Technology
  • 7.3.5. Spain Transfection Technologies Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Transfection Method
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Technology

8. Asia Pacific Transfection Technologies Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Transfection Method
  • 8.2.2. By Product
  • 8.2.3. By Application
  • 8.2.4. By Technology
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Transfection Technologies Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Transfection Method
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Technology
  • 8.3.2. India Transfection Technologies Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Transfection Method
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Technology
  • 8.3.3. Japan Transfection Technologies Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Transfection Method
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Technology
  • 8.3.4. South Korea Transfection Technologies Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Transfection Method
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Technology
  • 8.3.5. Australia Transfection Technologies Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Transfection Method
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Technology

9. Middle East & Africa Transfection Technologies Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Transfection Method
  • 9.2.2. By Product
  • 9.2.3. By Application
  • 9.2.4. By Technology
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Transfection Technologies Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Transfection Method
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Technology
  • 9.3.2. UAE Transfection Technologies Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Transfection Method
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Technology
  • 9.3.3. South Africa Transfection Technologies Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Transfection Method
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Technology

10. South America Transfection Technologies Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Transfection Method
  • 10.2.2. By Product
  • 10.2.3. By Application
  • 10.2.4. By Technology
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Transfection Technologies Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Transfection Method
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Technology
  • 10.3.2. Colombia Transfection Technologies Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Transfection Method
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Technology
  • 10.3.3. Argentina Transfection Technologies Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Transfection Method
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Technology

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Transfection Technologies Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Promega Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Thermo Fisher Scientific Inc.
• 15.3. Bio-Rad Laboratories, Inc.
• 15.4. Roche Molecular Systems, Inc.
• 15.5. QIAGEN NV
• 15.6. Inovio Pharmaceuticals
• 15.7. Mirus Bio LLC
• 15.8. Takara Bio Inc.
• 15.9. SignaGen Laboratories
• 15.10. MaxCyte, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer